PMC:5848803 / 14485-17097 JSONTXT

{"project":"testtesttest","denotations":[{"id":"T33","span":{"begin":428,"end":434},"obj":"Body_part"},{"id":"T34","span":{"begin":1603,"end":1608},"obj":"Body_part"},{"id":"T35","span":{"begin":1639,"end":1644},"obj":"Body_part"},{"id":"T36","span":{"begin":1959,"end":1972},"obj":"Body_part"},{"id":"T37","span":{"begin":2242,"end":2249},"obj":"Body_part"},{"id":"T38","span":{"begin":2329,"end":2335},"obj":"Body_part"},{"id":"T39","span":{"begin":2470,"end":2475},"obj":"Body_part"},{"id":"T43","span":{"begin":2603,"end":2610},"obj":"Body_part"}],"attributes":[{"id":"A33","pred":"uberon_id","subj":"T33","obj":"http://purl.obolibrary.org/obo/UBERON_0003100"},{"id":"A34","pred":"uberon_id","subj":"T34","obj":"http://purl.obolibrary.org/obo/UBERON_0003978"},{"id":"A35","pred":"uberon_id","subj":"T35","obj":"http://purl.obolibrary.org/obo/UBERON_0003978"},{"id":"A36","pred":"uberon_id","subj":"T36","obj":"http://purl.obolibrary.org/obo/UBERON_0001404"},{"id":"A37","pred":"uberon_id","subj":"T37","obj":"http://purl.obolibrary.org/obo/UBERON_0004529"},{"id":"A38","pred":"uberon_id","subj":"T38","obj":"http://purl.obolibrary.org/obo/UBERON_0002113"},{"id":"A39","pred":"uberon_id","subj":"T39","obj":"http://purl.obolibrary.org/obo/UBERON_0000948"},{"id":"A40","pred":"uberon_id","subj":"T39","obj":"http://purl.obolibrary.org/obo/UBERON_0007100"},{"id":"A41","pred":"uberon_id","subj":"T39","obj":"http://purl.obolibrary.org/obo/UBERON_0015228"},{"id":"A42","pred":"uberon_id","subj":"T39","obj":"http://purl.obolibrary.org/obo/UBERON_0015230"},{"id":"A43","pred":"uberon_id","subj":"T43","obj":"http://purl.obolibrary.org/obo/UBERON_0004529"}],"text":"Distribution of baseline characteristics for both matched analyses A and B was similar between groups (Table 3).\nTable 3 Pre- and intraoperative characteristics of patients in matched analysis\nCharacteristic Matched Analysis A Matched Analysis B\nRedo-OPCAB (n = 111) Redo-CABG (n = 111) P-value SMD* Redo-OPCAB (n = 88) Redo-CABG (n = 88) P-value SMD*\nAge (years) 67.8 (8.6) 67.9 (7.2) 0.53 0.01 67.3 (7.7) 67.7 (7.5) 0.74 0.05\nFemale gender (%) 15 (13) 12 (11) 0.54 0.08 11 (13) 9 (11) 0.65 0.07\nBMI (kg/m2) 27.4 (3.7) 27.1 (4) 0.49 0.09 27.8 (3.9) 27.4 (4.3) 0.65 0.08\nReduced LVEF \u003c50% 40 (36) 38 (34) 0.78 0.04 29 (34) 30 (36) 0.86 0.03\nDiabetes (%) 26 (23) 29 (26) 0.63 0.06 19 (23) 23 (27) 0.44 0.11\nHypertension (%) 83 (75) 81 (73) 0.76 0.04 60 (71) 62 (74) 0.70 0.05\nCKD (%) 1 (1) 1 (1) 1.00 \u003c0.01 0 (0) 1 (1) NA 0.16\nPreop creatinine (µmol/l) 100.1 (25.4) 102 (29) 0.76 0.07 96.7 (20) 98.6 (24) 0.82 0.08\neGFR (ml/min/1.73 m2) 66 (16) 65.8 (18) 0.84 0.01 67.9 (16) 67.7 (17.7) 0.83 0.01\nPrevious CVA (%) 15 (13) 14 (13) 0.84 0.03 9 (11) 9 (11) 1.00 \u003c0.01\nPVD (%) 23 (21) 25 (22) 0.73 0.04 13 (15) 15 (18) 0.66 0.06\nCOPD (%) 20 (18) 17 (15) 0.59 0.07 10 (12) 8 (9) 0.59 0.08\nSmoking history (%) 82 (73) 81 (73) 0.88 0.02 65 (78) 60 (71) 0.35 0.14\nEuroSCORE 7 (2.7) 6.9 (2.7) 0.83 0.05 7.1 (2.5) 7.2 (2.8) 0.71 0.06\nNYHA Class 3/4 (%) 43 (39) 44 (40) 0.89 0.02 35 (42) 33 (39) 0.76 0.05\nCCS Class 3/4 (%) 67 (60) 73 (66) 0.43 0.11 57 (68) 55 (65) 0.73 0.05\nUrgent surgery (%) 44 (40) 48 (44) 0.57 0.07 33 (39) 28 (33) 0.41 0.12\nPrevious type of surgery (%) 0.91 0.06\n CABG 84 (76) 83 (75) NA NA\n Valve 16 (14) 18 (16) NA NA\n CABG + valve ± other 11 (10) 10 (9) NA NA\nNumber of diseased vessels 2.4 (0.7) 2.4 (0.7) 0.79 0.03 2.3 (0.8) 2.4 (0.7) 0.29 0.13\nUse of nitrates (%) 18 (16) 17 (15) 0.84 0.03 11 (13) 10 (12) 0.78 0.04\nNo of grafts 2.1 (0.8) 2.4 (0.8) \u003c0.01 2 (0.8) 2.2 (0.8) 0.03\nUse of IMA (%) 62 (56) 52 (47) 0.21 44 (51) 29 (34) 0.02\nUse of radial artery (%) 24 (22) 19 (17) 0.39 20 (24) 16 (19) 0.47\nData are reported as mean and SD for continuous variables and as total count and percentages for categorical variable.\nSMD: standardized mean difference (reported for the variables included in the propensity score matching process); BMI: body mass index; LVEF: Left ventricular ejection fraction; CKD: chronic kidney disease; CVA: cerebrovascular accident; PVD: peripheral vascular disease; COPD: chronic obstructive pulmonary disease; NYHA: New York Heart Association; CCS: Canadian Cardiovascular Society.\na SMD (reported for the variables included in the propensity score-matching process)."}